Melissa Beelen - 29 Jul 2021 Form 3 Insider Report for IN8BIO, INC. (INAB)

Role
VP, Clinical Operation
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 21:33:49 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INAB Employee Stock Option (right to buy) 29 Jul 2021 Common Stock 39,184 $1.07 Direct F1
holding INAB Employee Stock Option (right to buy) 29 Jul 2021 Common Stock 13,140 $1.23 Direct F2
holding INAB Employee Stock Option (right to buy) 29 Jul 2021 Common Stock 57,434 $6.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option vested on April 1, 2020, and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on June 1, 2021, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
F3 Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2021, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney